Market Place
Sourcing Support
Amydis Secures $2.5M NIH Grant For ALS Biomarker Eye Test
14 Mar 2026 //
INDPHARMAPOST
Amydis Secures Phase 2 NIH Grant For TDP-43 Biomarker Detection
11 Mar 2026 //
PR NEWSWIRE
Amydis To Present First Ocular Tracer For ATTR At AAOOP Conference
10 Oct 2024 //
GLOBENEWSWIRE
Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award
14 Nov 2023 //
GLOBENEWSWIRE
Amydis Launches Phase 2 Glaucoma Clinical Program
02 Nov 2023 //
GLOBENEWSWIRE
Amydis Announces Enrollment of Participants in Phase 1/2a Retinal Tracer Trial
21 Feb 2023 //
GLOBENEWSWIRE
Amydis Awarded Third Grant From The Michael J. Fox Foundation
27 Oct 2022 //
GLOBENEWSWIRE
Amydis Announces Enrollment of First Participants in PROBE, a Phase 1/2a
22 Sep 2022 //
GLOBENEWSWIRE
Amydis Receives NIH Grant Award to Develop a Novel TDP-43 Retinal Tracer
18 Aug 2022 //
GLOBENEWSWIRE
Amydis Appoints Dr. Robert N. Weinreb as 1st Chair of Scientific Advisory Board
04 Apr 2022 //
GLOBENEWSWIRE
Amydis Awarded $3 M NIH Grant to Explore Novel Alpha Synuclein Retinal Tracer
11 Oct 2021 //
GLOBENEWSWIRE
Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer
02 Sep 2021 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.